Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia.

Blood advances - 14 May 2024

Richardson Kris, Castillo Jorge J, Sarosiek Shayna R, Branagan Andrew R, Flynn Catherine A, Meid Kirsten, Gustine Joshua N, Liu Xia, Kofides Amanda, Liu Shirong, Wolf Julie L, Kacena Katherine A, Patterson Christopher J, Guerrera Maria Luisa, Tsakmaklis Nicholas, Treon Steven P, Hunter Zachary R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Multiomics
Share to Myeloid Differentiation Factor 88

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Piperidines

Share to Pyrazoles

Share to Pyrimidines

Share to Treatment Outcome

Share to Waldenstrom Macroglobulinemia

Source

Open in PubMed Open full text

Identifiers

PMID: 38237078
DOI: 10.1182/bloodadvances.2023012111
PMCID: PMC11059321

Genes

MYD88

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia.PMID 38237078Read ↗

Distinct immune and genomic signatures predict resistance to ibrutinib therapy in Waldenström macroglobulinemiaSemantic proximity Read ↗

Genomic evolution of ibrutinib‐resistant clones in Waldenström macroglobulinaemiaSemantic proximity Read ↗

Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond.Semantic proximity Read ↗

Beyond single biomarkers: multi-omics strategies to predict immunotherapy outcomes in blood cancersSemantic proximity Read ↗

<i>MYD88</i> Mutations and Response to Ibrutinib in Waldenström's MacroglobulinemiaSemantic proximity Read ↗

Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaSemantic proximity Read ↗

Decoding Waldenström Macroglobulinemia Through Genomics, Epigenomics and Cellular Interactions.Semantic proximity Read ↗

Novel Treatment Strategies in the Management of Waldenström Macroglobulinemia.Semantic proximity Read ↗

Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.Semantic proximity Read ↗

Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

Deciphering Ibrutinib Resistance in Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.